A recent study published in Current Molecular Pharmacology demonstrates that puerarin-a bioactive isoflavone derived from ...

GSK (LSE:GSK) and Engitix Ltd. have agreed a research collaboration focused on discovering new treatments for liver fibrosis. The partnership uses Engitix’s human extracellular matrix platform and ...

New research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis and suggests a novel treatment approach for this common and serious condition ...

The research group led by CIC biomaGUNE's Ikerbasque Research Professor Aitziber L. Cortajarena has developed an innovative ...

Spatial biology technologies are reshaping modern biomedical research by enabling the visualization of cellular organization ...

Patients with untreated chronic hepatitis B who had metabolic comorbidities were at a higher risk for advanced liver fibrosis and were less likely to see improvement with antiviral therapy than those ...

Hepatic fibrosis is marked by the excessive deposition of extracellular matrix proteins in response to chronic liver injury, underpinning the progression to cirrhosis and organ failure. Cytokines, as ...

Hepatic fibrosis arises from sustained liver injury of diverse aetiologies, including viral hepatitis, alcohol misuse and metabolic dysfunction. Central to its pathogenesis is the activation of ...

KATY, TX / ACCESS Newswire / June 16, 2026 / In April 2026, a groundbreaking study-Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis-was published online in ...

When managing patients with hepatitis C virus (HCV), initiating treatment of the infection promptly is more important than determining the severity of their liver disease with the customary staging ...

A review included more than 600,000 people to highlight that what we eat—not just what we drink—impacts liver health.